,,iii  #aae? ,,congress  #b;d ,session  
,s4 ,,res4 #dhd  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,april #be1 #bjah ,mr4
 ,isakson 7= himself & ,ms4 ,/ab5[7     
submitt$ ! foll[+ resolution2 :i* 0     
consid]$ & agre$ to  ,,resolution       
,support+ ! designation ( ,april #bjah z
 ,p>k9son's ,aw>5ess ,mon?4  ,:]eas     
,p>k9son's disease is a *ronic1         
progressive neurological disease & is ! 
second mo/ common neurodeg5]ative       
disease 9 ! ,unit$ ,/ates2 ,:]eas !re is
 inadequate data on ! incid5ce &        
preval5ce ( ,p>k9son's disease1 b x is  
e/imat$ to affect ne>ly #a1jjj1jjj      
individuals 9 ! ,unit$ ,/ates1 ) t numb]
 expect$ to m ?an d\ble by #bjdj2 ,:]eas
 ,p>k9son's disease is ! #ad? lead+     
cause ( dea? 9 ! ,unit$ ,/ates accord+  
to ! ,c5t]s = ,disease ,control &       
,prev5tion2 ,:]eas millions (           
individuals 9 ! ,unit$ ,/ates are       
c>egiv]s1 family memb]s1 & fri5ds :o are
 greatly impact$ by ,p>k9son's disease2 
,:]eas rese>* sugge/s ! cause (         

,p>k9son's disease is a comb9ation (    
g5etic & environm5tal factors1 b ! exact
 cause 9 mo/ individuals is /ill unkn[n2
 ,:]eas !re is curr5tly no objective te/
 or biom>k] to diagnose ,p>k9son's      
disease2 ,:]eas !re is no kn[n cure or  
drug to sl[ or halt ! progression (     
,p>k9son's disease1 & available         
treatm5ts are limit$ 9 _! ability to    
address ! m$ical ne$s ( pati5ts & rema9 
effective ov] "t2 ,:]eas ! symptoms (   
,p>k9son's disease v>y f p]son to p]son 
& c include-- 7#a7 tremors2  7#b7       
sl[ness ( movem5t & rigidity2  7#c7 gait
 & balance difficulty2  7#d7 spee* &    
swall[+ di/urbances2  7#e7 cognitive    
impairm5t & dem5tia2  7#f7 mood         
disord]s2 &  7#g7 a v>iety ( o!r        
non-motor symptoms2  ,:]eas volunte]s1  
rese>*]s1 c>egiv]s1 & m$ical            
pr(essionals are work+ to improve !     
quality ( life ( individuals liv+ )     
,p>k9son's disease & _! families2 &     
,:]eas increas$ rese>*1 education1 &    
community support s]vices are ne$$ to   

f9d m effective treatm5ts & to provide  
access to quality c>e to ^? liv+ )      
,p>k9son's disease today3 ,n[1 !re=e1 be
 x  ,t ! ,s5ate-- 7#a7 designates ,april
 #bjah z ,p>k9son's ,aw>5ess ,mon? 2    
7#b7 supports ! goals & ideals (        
,p>k9son's ,aw>5ess ,mon?2  7#c7        
cont9ues to support rese>* to f9d bett] 
treatm5ts & a cure = ,p>k9son's disease2
  7#d7 recognizes ! individuals liv+ )  
,p>k9son's disease :o p>ticipate 9 vital
 cl9ical trials to advance ! k ( !      
disease2 &  7#e7 comm5ds ! d$ication (  
organizations1 volunte]s1 rese>*]s1 &   
millions ( individuals across ! c\ntry  
work+ to improve ! quality ( life (     
individuals liv+ ) ,p>k9son's disease & 
_! families4